Session IV: Dyslipidemia/Atherosclerosis/Thrombosis

Challenging Lipid Management Cases with Expert Panel Discussion and Audience Q&A

Moderator(s)

• 

  Christie M. Ballantyne, MD (he/him/his)

  Professor of Medicine
  Baylor College of Medicine
  Baylor College of Medicine
  Houston, Texas, United States

Panelist(s)

• 

  Erin D. Michos, MD, MHS (she/her/hers)

  Director of Women's Cardiovascular Health
  Johns Hopkins University School of Medicine
  Johns Hopkins University School of Medicine
  Baltimore, Maryland, United States
• 

  Pradeep Natarajan, MD, MMSc (he/him/his)

  Director of Preventive Cardiology, Mass General Hospital Paul and Phyllis Fireman Endowed Chair in Vascular Medicine, Mass General Hospital Associate Director of Personalized Medicine, Mass General Brigham Associate Professor of Medicine, Harvard Medical School Associate Professor of Epidemiology, Harvard T.H. Chan School of Public Health Associate Member, Broad Institute of Harvard and MIT Director of Preventive Cardiology
  Mass General Hospital
  Harvard University
  Brookline, Massachusetts, United States
• 

  Paul M. Ridker, MD, MPH (he/him/his)

  Director, Center for Cardiovascular Disease Prevention
  Brigham and Women's Hospital
  Harvard Medical School
  Brookline, Massachusetts, United States
• 

  Pam R. Taub, MD, FACC

  Professor of Medicine
  UC San Diego
  UC San Diego
  La Jolla, California, United States
• 

  Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA (she/her/hers)

  Director, Seinsheimer Cardiovascular Health ProgramPaul V Kramer Chair of Cardiovascular Disease Prevention
  The Medical University of South Carolina
  The Medical University of South Carolina
  Mount Pleasant, South Carolina, United States
• 

  Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC

  Director of Atherosclerosis and Lipoprotein-apheresis Center Pharmacology
  The University of Kansas Health System
  Kansas University Medical Center
  Kansas City, Kansas, United States